Brief: Endo Comments On Non-Infringement Ruling In VASOSTRICT Patent Litigation
31/08/2021 19:13
Aug 31 (Reuters) - Endo International PLC ENDP.O :
* ENDO COMMENTS ON NON-INFRINGEMENT RULING IN VASOSTRICT®
PATENT
LITIGATION
* ENDO INTERNATIONAL PLC - BECAUSE COURT FOUND
NON-INFRINGEMENT OF
ENDO'S PATENTS BY EAGLE'S PROPOSED PRODUCT, IT DID NOT RULE ON
PATENTS' VALIDITY
* ENDO INTERNATIONAL PLC - TO APPEAL COURT'S DECISION AND
CONTINUE
DEFENDING INTELLECTUAL PROPERTY RIGHTS TO VASOSTRICT
Source text for Eikon: urn:newsml:reuters.com:*:nCNWSvnvBa
Further company coverage: ENDP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eagle Pharmaceuticals
See all newsDoes a common heart attack pill help everyone? Studies disagree
Brief: Eagle Pharmaceuticals Says Continuing To Evaluate Its Internal Control Over Financial Reporting
Brief: Nantahala Capital Management, Llc Reports 15.1% Passive Stake In Eagle Pharmaceuticals Inc As Of June 30- SEC Filing
Brief: Eagle Pharmaceuticals Says On May 28, Co Requested Hearing Before Hearings Panel Of Nasdaq, Following Delisting Notice From Nasdaq - SEC Filing
Brief: Eagle Pharmaceuticals Announces Receipt Of Delisting Notification From Nasdaq